292 related articles for article (PubMed ID: 15564772)
1. Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor.
Wu RL; Anthes JC; Kreutner W; Harris AG; West RE
Int Arch Allergy Immunol; 2004 Dec; 135(4):313-8. PubMed ID: 15564772
[TBL] [Abstract][Full Text] [Related]
2. Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms.
Roumestan C; Henriquet C; Gougat C; Michel A; Bichon F; Portet K; Jaffuel D; Mathieu M
Clin Exp Allergy; 2008 Jun; 38(6):947-56. PubMed ID: 18498541
[TBL] [Abstract][Full Text] [Related]
3. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
Kreutner W; Hey JA; Anthes J; Barnett A; Young S; Tozzi S
Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633
[TBL] [Abstract][Full Text] [Related]
4. Effect of desloratadine and loratadine on rhinovirus-induced intercellular adhesion molecule 1 upregulation and promoter activation in respiratory epithelial cells.
Papi A; Papadopoulos NG; Stanciu LA; Degitz K; Holgate ST; Johnston SL
J Allergy Clin Immunol; 2001 Aug; 108(2):221-8. PubMed ID: 11496238
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activity of the histamine H(1) receptor reveals inverse agonism of histamine H(1) receptor antagonists.
Bakker RA; Wieland K; Timmerman H; Leurs R
Eur J Pharmacol; 2000 Jan; 387(1):R5-7. PubMed ID: 10633171
[TBL] [Abstract][Full Text] [Related]
6. Desloratadine citrate disodium injection, a potent histamine H(1) receptor antagonist, inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and NF-kappa B signal cascades.
Chen M; Xu S; Zhou P; He G; Jie Q; Wu Y
Eur J Pharmacol; 2015 Nov; 767():98-107. PubMed ID: 26455479
[TBL] [Abstract][Full Text] [Related]
7. Impact of desloratadine and loratadine on the crosstalk between human keratinocytes and leukocytes: Implications for anti-inflammatory activity of antihistamines.
Traidl-Hoffmann C; Münster I; Ring J; Behrendt H
Int Arch Allergy Immunol; 2006; 140(4):315-20. PubMed ID: 16741367
[TBL] [Abstract][Full Text] [Related]
8. Anti-allergic and anti-inflammatory properties of a potent histamine H1 receptor antagonist, desloratadine citrate disodium injection, and its anti-inflammatory mechanism on EA.hy926 endothelial cells.
Jie Q; Kodithuwakku ND; Yuan X; He G; Chen M; Xu S; Wu Y
Eur J Pharmacol; 2015 May; 754():1-10. PubMed ID: 25704613
[TBL] [Abstract][Full Text] [Related]
9. Comparative anticholinergic activities of 10 histamine H1 receptor antagonists in two functional models.
Orzechowski RF; Currie DS; Valancius CA
Eur J Pharmacol; 2005 Jan; 506(3):257-64. PubMed ID: 15627436
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of histamine H1 receptor activity modulates proinflammatory cytokine production of dendritic cells through c-Rel activity.
Lee CL; Hsu SH; Jong YJ; Hung CH; Suen JL
Int Arch Allergy Immunol; 2013; 160(3):265-74. PubMed ID: 23075496
[TBL] [Abstract][Full Text] [Related]
11. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.
Leurs R; Church MK; Taglialatela M
Clin Exp Allergy; 2002 Apr; 32(4):489-98. PubMed ID: 11972592
[TBL] [Abstract][Full Text] [Related]
12. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
Kłos K; Kruszewski J; Kruszewski R; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
[TBL] [Abstract][Full Text] [Related]
13. Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine.
Glass DJ; Harper AS
BMC Fam Pract; 2003 Aug; 4():10. PubMed ID: 12917016
[TBL] [Abstract][Full Text] [Related]
14. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
Munoz-Cano R; Ainsua-Enrich E; Torres-Atencio I; Martin M; Sánchez-Lopez J; Bartra J; Picado C; Mullol J; Valero A
J Investig Allergol Clin Immunol; 2017; 27(3):161-168. PubMed ID: 27758758
[TBL] [Abstract][Full Text] [Related]
15. Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor.
Anthes JC; Gilchrest H; Richard C; Eckel S; Hesk D; West RE; Williams SM; Greenfeder S; Billah M; Kreutner W; Egan RE
Eur J Pharmacol; 2002 Aug; 449(3):229-37. PubMed ID: 12167464
[TBL] [Abstract][Full Text] [Related]
16. Comparative activity of cetirizine and desloratadine on histamine-induced wheal-and-flare responses during 24 hours.
Purohit A; Melac M; Pauli G; Frossard N
Ann Allergy Asthma Immunol; 2004 Jun; 92(6):635-40. PubMed ID: 15237765
[TBL] [Abstract][Full Text] [Related]
17. Histamine H(1)-receptor activation of nuclear factor-kappa B: roles for G beta gamma- and G alpha(q/11)-subunits in constitutive and agonist-mediated signaling.
Bakker RA; Schoonus SB; Smit MJ; Timmerman H; Leurs R
Mol Pharmacol; 2001 Nov; 60(5):1133-42. PubMed ID: 11641442
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological activity evaluation of desloratadine analogues as H1 receptor antagonists.
Lin Y; Wang Y; Sima LF; Wang DH; Cao XH; Chen LG; Chen B
Bioorg Med Chem; 2013 Jul; 21(14):4178-85. PubMed ID: 23719280
[TBL] [Abstract][Full Text] [Related]
19. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
20. [The place of new antihistamines in allergy management. Apropos of desloratadine].
Sabbah A
Allerg Immunol (Paris); 2002 Dec; 34(10):377-83. PubMed ID: 12575624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
